1. Home
  2. VRDN vs BBN Comparison

VRDN vs BBN Comparison

Compare VRDN & BBN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VRDN
  • BBN
  • Stock Information
  • Founded
  • VRDN 2006
  • BBN 1983
  • Country
  • VRDN United States
  • BBN United States
  • Employees
  • VRDN N/A
  • BBN N/A
  • Industry
  • VRDN Medical Specialities
  • BBN Finance Companies
  • Sector
  • VRDN Health Care
  • BBN Finance
  • Exchange
  • VRDN Nasdaq
  • BBN Nasdaq
  • Market Cap
  • VRDN 1.6B
  • BBN 1.0B
  • IPO Year
  • VRDN N/A
  • BBN N/A
  • Fundamental
  • Price
  • VRDN $21.46
  • BBN $16.66
  • Analyst Decision
  • VRDN Strong Buy
  • BBN
  • Analyst Count
  • VRDN 10
  • BBN 0
  • Target Price
  • VRDN $36.33
  • BBN N/A
  • AVG Volume (30 Days)
  • VRDN 708.8K
  • BBN 231.8K
  • Earning Date
  • VRDN 11-11-2025
  • BBN 01-01-0001
  • Dividend Yield
  • VRDN N/A
  • BBN 6.90%
  • EPS Growth
  • VRDN N/A
  • BBN N/A
  • EPS
  • VRDN N/A
  • BBN N/A
  • Revenue
  • VRDN $305,000.00
  • BBN N/A
  • Revenue This Year
  • VRDN N/A
  • BBN N/A
  • Revenue Next Year
  • VRDN $34,044.63
  • BBN N/A
  • P/E Ratio
  • VRDN N/A
  • BBN N/A
  • Revenue Growth
  • VRDN 5.90
  • BBN N/A
  • 52 Week Low
  • VRDN $9.90
  • BBN $14.33
  • 52 Week High
  • VRDN $27.20
  • BBN $18.36
  • Technical
  • Relative Strength Index (RSI)
  • VRDN 60.28
  • BBN 57.75
  • Support Level
  • VRDN $20.69
  • BBN $16.46
  • Resistance Level
  • VRDN $22.37
  • BBN $16.71
  • Average True Range (ATR)
  • VRDN 0.97
  • BBN 0.14
  • MACD
  • VRDN -0.00
  • BBN 0.01
  • Stochastic Oscillator
  • VRDN 74.14
  • BBN 63.43

About VRDN Viridian Therapeutics Inc.

Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. Its product candidate includes Veligrotug (formerly known as VRDN-001) for intravenous (IV) and VRDN-003 for subcutaneous (SC) administration. Veligrotug is a differentiated humanized monoclonal antibody targeting IGF-1R intravenously administered for the treatment of thyroid eye disease (TED).

About BBN BlackRock Taxable Municipal Bond Trust of Beneficial Interest

BlackRock Taxable Municipal Bond Trust is a diversified, closed-end management investment company. Its investment objective is to seek high current income, with a secondary objective of capital appreciation.

Share on Social Networks: